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C57BL/6 miceLeishmania/L. major was identiﬁed as the etiological agent of human localized cutaneous leishmaniasis. L. major
metacyclic promastigotes/MP – the infectious form transmitted by sand ﬂies – were enriched from axenically-
derived cultures and inoculated into the dermis of mice (103 or 104 luciferase-expressing L. majorMP inoculated
into the C57BL/6 mouse ear pinna). Quantitative readout assays were then combined with imaging of this
L. major-hosting skin site and established i) that a speciﬁc period of time – depending upon the L. major load
used for the inoculation – is required for the L. major-hosting ear pinna to be continuously populated by a
balanced population of functional regulatory and effector T lymphocytes, and that ii) this balance coincides
with persisting low numbers of amastigotes in more or less rapidly healing skin. This approach also established
that,whatever theMP inoculum loaddelivered to the primary site, the immuneprocesses that reduce the L.major
amastigote population also account for concomitant immunity, namely remodelling of the secondary site –
where 104 MP were delivered – as a clinically silent niche hosting a small L. major population.
© 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.1. Introduction
Leishmania/L. major is a protozoan parasite that is transmitted to the
dermis of its mammalian hosts by blood-feeding sand ﬂies [1,2]. By
studying the dynamics of the Leishmania-driven process in human and
non-human Leishmania-hostingpopulations,we aim to unveil and char-
acterize in real time each step in this pathogenesis. Recently, laboratory
mice were recognized as model mammals displaying features of bona
ﬁde hosts [3–6]. The C57BL/6mouse appears to be themost relevant ex-
perimental host for studying cutaneous leishmaniasis caused by L.major
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experimental conditions based on luciferase-expressing L. majormeta-
cyclic promastigotes/MP enriched from L. major cultures, i.e. the infec-
tious forms transmitted by sand ﬂies and C57BL/6 mice [8–11]. The
capacity to record in real time and integrate quantitative multi-
parametric datasets from L. major-hostingmice provides the opportuni-
ty to decipher the infectious processes developing during the different
phases that follow the delivery of parasites [12].
To determine whether the dynamic processes that account for
Leishmania perpetuation differs after inoculation with different doses
of L. majorMP,we analysed the infectious process in C57BL/6mice inoc-
ulated in ear pinna dermis with a physiological inoculum of either 103
or 104 luciferase-expressing transgenic L. major. We then simultaneous-
ly analysed i) parasite load ﬂuctuations, ii) onset of lesion development,
iii) inﬂammatory processes and iv) immunity-related processes in both
the inoculated ear and the draining lymph node/DLN. This imaging and
quantitative analysis of both Leishmania and mouse transcripts showed
that a speciﬁc period of time – depending upon the quantity of L. major
inoculum – is required for the L. major-hosting ear pinna to be continu-
ously populated by a balanced population of functional regulatory and
effector T lymphocytes, and that this balance coincides with persisting
low numbers of amastigotes in more or less rapidly healing ear pinna.
This multiplex approach also established that, whatever the quantity
ofMP inoculumdelivered to theﬁrst site, the immuneprocesses that re-
duce the L. major amastigote population also account for concomitant-ND license.
Table 1
Housekeeping and target genes, and characteristics of primers and ampliﬁcation products.
Gene
name
Source Primer sequences (5′3′) Amplicons
Tm Length
G6PD Probe design FW 5′GAAACTGACAACGTGGT3′ 84.26 381
RV 5′GCCATAAGTTAGATCCAGC3′
H6PD Probe design FW 5′GGATTGTGTTTAAGAATCGGG3′ 86.15 270
RV 5′AGTAGGCGTCTTGCTC3′
IL-2 Probe design FW 5′AGGAACCTGAAACTCCC3′ 79.59 259
RV 5′AGTCCACCACAGTTGC3′
IL-4 Probe design FW 5′GGAGCCATATCCACGG3′ 81.98 159
RV 5′AAGCCCTACAGACGAG3′
IL12p40 Probe design FW 5′CTGGCGTTGGAAGCAC3′ 82.22 259
RV 5′TGCATTGGACTTCGGT3′
IFN-γ Probe design FW 5′CTTCTTCAGCAACAGCAAGG3′ 79.6 101
RV 5′TGAGCTCATTGAATGCTTGG3′
TGFβ Probe design FW 5′GCGGACTACTATGCTAAAGA 82 243
RV 5′GTAACGCCAGGAATTGT
IL-10 Probe design FW 5′CCAAGCCTTATCGGAAATG 80.1 121
RV 3′CCTGAGGGTCTTCAGC
CD4 Probe design FW 5′ACAACTCCTAGCTGTCAC 82.4 155
RV 3′CACCTTTGCCATGCTG
CD8 Probe design FW 5′TCCTACAACTGCCCCA 84 171
RV 3′AAGTAGACGGCCACTC
Foxp3 Probe design FW 5′ACCATTGGTTTACTCGC 82.92 151
RV 3′CGAAACTCAAATTCATCTACGG
FW, Forward primer; RV, Reverse primer; Tm, melting temperature is the temperature at
which 50% of the DNA is single stranded.
G6PD, Glucose-6-phosphate dehydrogenase.
H6PD, Hexose-6-phosphate dehydrogenase/Glucose-1 dehydrogenase.
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were delivered – as a clinically silent niche hosting a small L. major
population.
2. Materials and methods
2.1. Parasites
L. major strain NIH 173 (MHOM/IR/-/173) was used in the present
study. The procedure for integrating ﬁreﬂy luciferase in the nuclear
genome of this L. major strain has been reported previously [8,9].
2.2. Ethics statement
All animalswere housed in our A3 animal facility in compliancewith
the relevant guidelines in force at Pasteur Institutewhich is amember of
the “Comité d'Ethique pour l'Expérimentation Animale” (CEEA) — Ile de
France. Animal housing conditions and the procedures used in the
work described herein were approved by the “Direction des Transports
et de la Protection du Public, Sous-Direction de la Protection Sanitaire et
de l'Environnement, Police Sanitaire des Animaux” under number B75-
15-28 in accordance with the Ethics Charter of animal experimentation
that includes appropriate procedures to minimize pain and animal suf-
fering. TL is authorized to perform experiments on vertebrates (licence
75-717 issued by the Paris Department of Veterinary Services, DDSV)
and was responsible for all the experiments conducted personally or
under his supervision as governed by the laws and regulations relating
to the protection of animals.
2.3. Enrichment of luciferase-expressing L. major MP from axenic cultures
and inoculation in the C57BL/6 mouse ear pinna
Transgenic luciferase-expressing L. major amastigotes were isolated
from parasitized Swiss nude mice inoculated 2 months previously in a
BSL-2 cabinet [8]. The amastigote population was seeded at 26 °C in
supplementedM199mediumaspreviously described [13]; these axenic
conditions resulted in amastigote differentiation as ﬂagellated extracel-
lular promastigotes that rapidly entered the cell-cycle [8,9]. Six days
later, the stationary-phase promastigote population was loaded onto a
discontinuous density gradient [14] to enrich the small MP population.
C57BL/6 mice were anaesthetized by intraperitoneal administration
of a mixture of ketamine (120 mg/kg Imalgene 1000, Merial, France)
and xylasine (4 mg/kg; Rompun 2%, Bayer, Leverkusen, Germany). One
thousand to 10,000 MP in 10 μl of Dulbecco's phosphate buffered saline
(PBS) were injected into the dermis of the right ear pinna. Each mouse
was tagged in the contralateral left ear for identiﬁcation. Of note, the
left ears of mice used to monitor the time point at which concomitant
immunity was established were left untagged since used as the second
skin site inoculated with 104 MP. Ear thickness was measured directly
using vernier calipers (Thomas Scientiﬁc, Swedesboro, NJ).
2.4. In vivo luciferase-expressing L. major bioluminescence imaging
in tissues/organs
At different time points following inoculation of luciferase-
expressing L. major MP in the ear pinna dermis, C57BL/6 mice were
given luciferin 150 mg/kg i.p. then placed for purposes of anaesthesia
in a 2.5% isoﬂurane atmosphere (Aerane®, Baxter SA, Maurepas,
France) for 5 min before being transferred to the imaging chamber of
an IVIS™ Imaging System 100 Series (Xenogen). Emitted photons
were acquired by a charge-coupled device camera 25 min following
the luciferin inoculation in the previously deﬁned region of interest/
ROI that delimited the surface of the entire ear pinna. The same ROI
was examined in all mice at all time points. Total photon emission
was expressed in ph/s/ROI and median bioluminescence values and
standard deviations were calculated for each experimental group. Aspreviously described [12], a group of 3 representativemice, i.e. present-
ing median bioluminescence and standard deviation values similar to
the entire corresponding group, were sacriﬁced at designated time
points post-inoculation/PI, and the ear pinna and ear pinna-DLN were
removed for further process of total RNA extraction.
2.5. Experimental procedure used to determine the establishment of clini-
cal/concomitant immunity
C57BL/6 mice – 24 per experiment – were administered 104 or 103
luciferase-expressing transgenic L. major intradermally on day 0. On
day 22 (104 L. major) or 35 (103 L. major) post-inoculation, the left ear
pinna dermis was inoculated with 104 luciferase-expressing L. major
MP. A group of naive C57BL/6 mice given104 luciferase-expressing
L. majorMP in the left ear pinna was used as control.
2.6. Determination of L. major transcripts and mouse immune transcripts
by real time reverse transcription quantitative PCR (RT-qPCR) in the ear
pinna and ear pinna-DLN
Ear pinna and ear pinna DLN were removed and fragmented on a
Precellys 24 homogenizer as previously described [12]. Total RNA was
isolated using an RNeasy Plus Mini Kit (Qiagen, Courtaboeuf, France)
in accordance with the manufacturer's instructions. Total RNA was re-
verse transcribed to ﬁrst strand cDNA using random hexamers (Roche
Diagnostics) and Moloney Murine Leukemia Virus Reverse Transcrip-
tase (Invitrogen, Life Technologies). PCR was then performed as previ-
ously described [12,15]. Brieﬂy, PCR was performed in a ﬁnal volume
of 10 μl per reaction in white ultraAmp 384-well PCR plates (Sorenson
Bioscience, Inc., Salt Lake City, Utah, USA) using a LightCycler® 480 sys-
tem (Roche Diagnostics, Meylan, France). One microlitre of sample
(cDNA) was added to 9 μl of a master mix containing 5 μl of QuantiTect
SYBR Green Kit (Qiagen) and 4 μl of nuclease-free water with primers
(Guaranteed Oligos™, Sigma-Aldrich) at a ﬁnal concentration of 0.5 μM.
Housekeeping and target genes, and the characteristics of the primers
and ampliﬁcation products used are described in Table 1. Crossing
point values/Cp were determined by the second derivative maximum
method of the LightCycler 480 Basic Software. Raw Cp values were
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management and analysis [16]. For normalization calculations, g6pd and
h6pdwere selected as the most stable reference genes for the ear pinna
and ear pinna-DLN of C57BL/6 mice [12]. The Leishmania gene target
(ssrRNA) was selected for quantifying the number of parasites [12]. Two
mouse reference genes (see above) were used for normalization calcula-
tions. A linear regression for each standard curve was determined (num-
ber of Leishmania parasites against the relative expression of ssrRNA
values).
2.7. Statistical analyses
The correlation coefﬁcient and the p-value of the linear correlation
between bioluminescence values and real time RT-qPCR values for the
number of parasites were determined in the R statistical environment.
Two-sided Student's paired t-tests were used to test the RT-qPCR
value statistical signiﬁcance for immune transcripts between four
distinct phases during infectious process for each size of inoculums
(*: p b 0.05).
A Mann–Whitney test was used to compare, ear bioluminescence,
ear thickness and the number of parasites per ear obtained by RT-qPCR
between the control group and the group inoculated with parasites at
different time post-inoculation. The p values were calculated with a
Mann–Whitney test between mice inoculated with 104 and 103 for
the maximal bioluminescence values and the maximal ear thickness
(*: p b 0.05, **: p b 0.001, ***: p b 0.0001).
3. Results
3.1. Evidence for distinct macroscopic features, L. major population size
ﬂuctuations and clinical traits between C57BL/6 mice inoculated with 103
or 104 L. major MP
3.1.1. Multiparametric approach to delineate distinct phases in L. major-
hosting C57BL/6 mice
104 or 103 luciferase-expressing L. major MP were inoculated into
the ear pinna dermis of C57BL/6 mice (n = 24 mice in each group).
We then applied our combined methodology to both groups. First, ear
bioluminescence was imaged after injecting luciferin to monitor ﬂuctu-
ations in parasite load. Second, three representative animals were se-
lected from each group based on their bioluminescence imaging/BLI
values, as previously described [12]. Parasite-loaded ear pinna and the
corresponding DLNs were then harvested from each selected mouse in
parallel to control mice. These tissues were then processed by total
RNA extraction and the abundance of i) L. major and ii) mouse immune
transcripts was determined.
The bioluminescence values obtained for the L. major-hosting ear
pinna (Fig. 1A) showed three discrete phases in both experimental
groups. However no BLI variations could be detected for L. major
load values ≤2 × 105 (background value). This demonstrated that if
L. major-C57BL/6 mouse-driven processes are to be captured, it is ﬁrst
necessary to determine the abundance of L. major transcripts in the
early and late phases of L. major developmental in both ear pinna and
ear pinna DLN (when BLI values are below the background value).
3.1.2. Delineating three discrete phases in C57BL/6 ear pinna and ear pinna
DLN
Inoculation with 104 L. major MP (Fig. 1A, black boxes and whisker
plots) resulted in an initial early phase/EP (from day 0 to day 4
post-inoculation/PI) during which no signiﬁcant increase was detected
in bioluminescence. During this period, we used real time RT-qPCR
which has been shown to be 500 timesmore sensitive than biolumines-
cence [12], tomeasure the abundance of L. major transcripts. Only a low
number (1000) of live L. majorwas detected in the ear pinna on day 2 PI
(Fig. 1B, black histogram) despite theMP enrichment of the inoculationpopulation. It may therefore be concluded, during this early phase, that
approximately 10% of live L. majorwere undergoing the transition from
MP to amastigotes in the host cells. This EP phase was followed by a
bona ﬁde expansion phase/ExP of the L. major population thatwas read-
ily evidenced by a sharp increase in the bioluminescent signal from the
L. major-hosting ear pinna dermis which peaked on day 19 PI (Fig. 1A).
Our RT-qPCR technique conﬁrmed this result with L. major increasing
in the ear pinna from 2 × 104 to 4 × 106 between days 11 and 19 PI
(Fig. 1C; left panel). A strong correlation was observed between
L. major bioluminescence and transcript abundance values (correlation
coefﬁcient 0.71, p-value = 1.59 × 10−6; not shown). It should be noted
that during this ExP phase the intracellular amastigote population
showed a doubling time of 2 days in the ear pinna. L. major-hosting
ear pinna showed the ﬁrst clinical signs on day 11 PI, corresponding to
a leukocyte inﬁltrate-free tiny red spot (b2 mm2). The ﬁrst signiﬁcant
increase in L. major-hosting ear pinna thickness was noted only on day
16 PI (Fig. 1D). Therefore, during these EP and ExP phases of L. major
population establishment and expansion, no signiﬁcant correlation
was found between parasite load into the ear and the macroscopic fea-
tures of the L. major-hosting ear pinna (not shown). The next phase (day
20 to day 58 PI) of the L. major- and C57BL/6 mouse-driven process was
characterized by a signiﬁcantly and relatively sharp decrease in biolumi-
nescence whereas the ear pinna showed a bona ﬁde lesion similar to
human LCL (Fig. 1A, D, E). No correlation was noted between parasite
load and lesion area during this third phase that we called the reduction
phase/RP. It may therefore be concluded that lesion parameters reached
a maximum on day 29 (Fig. 1D, E, part a: ear pinna thickness around
1.1 mm: lesion area around 25 mm2), i.e. approximately 10 days after
the parasite load reached its maximum (Fig. 1A). Interestingly, the RT-
qPCR-based assay detected 2 × 103 amastigotes in the ear pinna on
day 58 PI, indicating that the L. major amastigotes were undergoing
transition to the persistence phase (Fig. 1C), a phase that was not
evidenced by bioluminescence because of the BLI background (see
Fig. 1A). But RT-qPCR on each L. major-hosting ear pinna DLN showed
i) a marked population expansion between day 11 and day 19 PI, ii) a
plateau from day 19 to day 37 PI, and iii) a population reduction by 58
PI, with 103 L. major still being detected (Fig. 1C, left panel).
The three phases we delineated following inoculation with 104
L. majorMP were also seen following inoculation with 103 L. majorMP
(Fig. 1A), while it was noted on day 2 PI that similarly less than 10% of
live L. major were undergoing the transition from MP to amastigotes
in the skin (Fig. 1B, grey histogram). The subsequent expansion of the
L. major population was detectable, by bioluminescence, only on day
19 PI (Fig. 1A), withmeanmaximumbioluminescence valuesmeasured
in L. major-hosting ear pinna being similar regardless of the number of
parasites administered and the number of live L. major remaining on
day 2 PI (Fig. 1F). Althoughmaximumparasite load precededmaximum
ear lesion thickness,we noted in themice given 104MP that the clinical-
ly detectable inﬂammatory process was i) more prolonged (Fig. 1D)
and ii) of a higher amplitude than in mouse ear pinna given 103 MP
(Fig. 1D, G). Of note, the plateau in L. major-hosting ear pinna DLN
was of a similar length regardless of the load administered. But this pla-
teau was delayed to day 35 PI in ear pinna DLNs given 103 MP, and the
peak value was 10 fold lower (Fig. 1C; right panel).3.2. Immune transcriptional signatures in L. major-hosting tissues
of C57BL/6 mice
As described previously [12], RT-qPCR was used along with two
housekeeping genes (internal controls — see Material and methods),
to follow ﬂuctuations in the parasite population andmeasure the abun-
dance of mouse immune transcripts in Leishmania spp.-hosting model
rodent tissues. Here, ear pinna and ear pinna DLN were sampled at six
different time points after inoculating with 103 or 104 L. major MP,
and transcript abundances for CD4, CD8β and Foxp3, and for a panel
Fig. 1. Simultaneousmeasurement of i) parasite load ﬂuctuations by bioluminescence/BLI and RT-qPCR, and ii) ear thickness in C57BL/6mice inoculatedwith 104 or 103 L.majormetacyclic
promastigotes/MP in the ear pinna. 104 or 103 L. majorMPwere inoculated into the dermis of C57BL/6 mouse ear pinna (n = 24mice per group). Results obtained frommice inoculated
with 104 and 103 L. majorMP are presented in black and grey respectively. A. Monitoring of BLI values at different time points post-inoculation. Box and whisker plots of BLI values show
range, 25th and 75th percentiles, and the median value at each time point. Maximum and minimum values are also shown as black dots. Three sequential phases – Early Phase (EP);
Expansion Phase (ExP), and Reduction Phase (RP) –were deﬁned for the two L. major inoculation loads. The background BLI value emitted from the ear pinna of control mice (i.e.mice
not given L. major) appears as the light grey area. Signiﬁcant differences between inoculated and control mice were calculated by the Mann–Whitney test (*p b 0.05, **p b 0.001,
***p b 0.0001). B. RT-qPCR quantitation of L. major numbers in ear pinna 2 days post-inoculation/PI. L. major transcripts were quantiﬁed by RT-qPCR in the ear pinna 2 days post-
inoculation. Ear RNA was extracted and reverse transcribed and the real time PCR assay was performed. As controls, three mock mice were used as calibrator for calculating relative ex-
pressions. The signiﬁcant difference between both groups is shown (Mann–Whitney test,*p b 0.05). C. RT-qPCRmonitoring of L. major numbers in both ear pinna and ear pinna draining
lymph node/DLN. L. major transcripts in the ear pinna and their DLNwere quantiﬁed by RT-qPCR. Both tissueswere collected at different time points post-L. major inoculation. Sensitivity
thresholds for ear pinna and ear pinna-DLN are indicated by the red and green areas respectively. Median values and standard deviations of one representative experiment of 3 indepen-
dent experiments are shown. Parasite load in the ear pinna and the DLN are presented as brown and green curves respectively. The left and the right panels correspond to the group in-
oculated with 104 or 103 MP respectively. D: Monitoring of ear thickness measurements in both groups up to 118 days PI. Ear thickness was measured at different time points PI. Median
and standard deviation values are shown. a, b, c and d correspond to representativemice of the 104 group (a, b) or the 103 group (c, d) thatwere taken in picture at day 29 (a, c) and day 57
(b, d). E: Illustration of the lesion deployment in representativemice at different time points. a, b, c and dmicewere selected as previously described andpictures of inoculated ear pinna of
these representative mice are shown at days 29 and 57 PI. Lesion area is indicated by the elliptic gate. F: Maximum BLI values (ph/s/ear) of ear pinna from individual mice from the 2
groups. Themaximum of BLI values for eachmouse of the two groups is presented. Themedian bioluminescence maxima is indicated by red bars. No signiﬁcant differencewas observed.
G.Maximumear thickness values (mm) of individualmice of the 2 groups. Themaximumof ear thickness of the inoculated ear pinna from eachmouse of the two groups is presented. The
median ear thickness maxima is indicated by red bars. The p value is indicated.
248 E. Giraud et al. / Parasitology International 63 (2014) 245–253of 6 cytokines (IL-2, IL-4, IL-10, TGF-β, IFN-γ, and IL-12p40)were simul-
taneously proﬁled over a period of 58 days. Figs. 2 and 3 and Tables 2
and 3 show changes in transcript abundance for each immune parame-
ter relative to tissues sampled from L. major-free mice.3.2.1. Proﬁles of CD4 and CD8β transcript abundances
In the ear pinna of mice inoculated with 104 parasites, CD4 T cell
transcripts slightly increased very early PI (Fig. 2; 5 +/− 2 fold increase
on day 4 PI). Levels then remained unchanged during the ExP (Fig. 2). In
Fig. 2. CD4, CD8β and Foxp3 transcript abundance in ear pinna of C57BL/6 mice (n = 24 in each group) inoculated with 104 or 103 L. major NIH 173MP. Ear pinnae were removed from
three representativemice at different time points. Total RNAwas extracted and reverse transcribed. Three control micewere used as calibrators for relative expression. The RT-qPCR assay
was performed as described inMaterial andmethods. CD4, CD8β and Foxp3 transcript abundances were determined in ear pinna over time post-inoculation with 104 (black line) or 103
(grey line). Values shown are mean fold changes in transcript abundances (n = 3 independent experiments). The 3 discrete phases post-inoculation are indicated.
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Then, CD4 transcript abundance in the ear pinna increased (Fig. 2, RP)
coupled with the decrease in parasite load that delineated the RP
(Fig. 1). Interestingly, CD8β transcript abundance proﬁles in the ear
pinna and DLN were slightly different: as the parasite load increased
at the inoculation site, i.e. during ExP, CD8β transcript levels ﬁrst rose
markedly in the DLN to reach a peak on day 15 PI (4 +/− 1.5 fold in-
crease, not shown). Peak CD8β transcript abundance levels were ob-
served 4 days later in the ear pinna (Fig. 2; 25 fold increase on day 19
PI), reﬂecting a clear decrease in CD8β transcript abundance in the
DLNs (1.02 +/− 0.12 on day 19 PI in DLN). CD8β transcript abundance
levels during the RP oscillated in the ear pinna between 20 and 25
(Fig. 2, Table 2). A slight increase was observed in the DLNs (Table 2).Fig. 3. IL-2, IL-4, IL-10, IL-12p40, IFN-γ and TGF-β cytokine transcript abundance in ear pinna of
pinnae were removed from three representativemice at different time points PI. Total RNAwas
expression. The RT-qPCR assay was performed as described in Material and methods. Transcrip
(grey line). Values shown are mean fold changes in transcript abundances (n = 3 independenIn C57BL/6 mouse ear pinna given 103 MP CD4 and CD8β transcript
abundances were signiﬁcantly different from that measured in the
C57BL/6 mouse ear pinna inoculated with 104 MP (Fig. 2, Table 2).
Therefore, the lower levels of T cell transcripts observed during the RP
could account for the lower amplitude of the transient inﬂammatory
processes shown by the L. major-hosting ear pinna.
3.2.2. Proﬁles of Foxp3 transcript abundance
In addition to Leishmania-reactive CD4 and CD8 effector T lympho-
cytes, both natural regulatory T lymphocytes and Leishmania-reactive
regulatory T lymphocyteswere expected to be recruited over the course
of our study in the L. major-hosting ear pinna. The results obtained for
Foxp3-coding transcript abundance suggested that two distinct wavesC57BL/6 mice (n = 24 in each group) inoculated with 104 or 103 L. majorNIH173MP. Ear
extracted and reverse transcribed. Three control mice were used as calibrators for relative
t abundance proﬁles in ear pinna over time post-inoculation with 104 (black line), or 103
t experiments).
Table 2
CD4, CD8β and Foxp3 transcript proﬁles in C57BL/6mice (n = 24 in each group) inoculated in ear pinna with 104 or 103 L. major NIH 173MP. CD4, CD8β and Foxp3 transcript proﬁles in
ear pinna and ear pinna-DLN over time, and particularly the temporal window spanning the early and expansion phase (EP–ExP) and the parasite reduction (RP) phase (see Fig. 2). Values
correspond to themean and standarddeviation of all the transcript values obtained in ear pinna or ear pinna-DLN during the corresponding phase. Values shown aremean fold changes for
transcripts.
* Signiﬁcant differences (p b 0.05) are indicated for transcript abundance measured in mice inoculated with 104 and 103 (n = 3 independent experiments).
Transcript Tissue EP–ExP RP
104 103 104 103
CD4 Ear 3.9 +/− 2.2 1.1 +/− 0.4 12.1 +/− 11.7 2.9 +/− 1.2
DLN 1.8 +/− 0.2 3.1 +/− 3.1 1.1 +/− 0.4 2.9 +/− 2.2
CD8β Ear 11.8 +/− 12.4 4.6 +/− 6.7 24.1 +/− 13.2 6.2 +/− 1.9
DLN 2.2 +/− 1.1 7.1 +/− 4.2 2.9 +/− 2.5 3.2 +/− 2.0
Foxp3 Ear 2.5 +/− 2.2 1.8 +/− 0.9 10.8 +/− 10.3 2.6 +/− 1.5
DLN 0.9 +/− 0.4 2.1 +/− 0.3 1.2 +/− 0.4 1.8 +/− 0.6
250 E. Giraud et al. / Parasitology International 63 (2014) 245–253of regulatory T lymphocytes were operating in the L. major-hosting
ear pinna over time. Brieﬂy, in C57BL/6 mice inoculated with 104 MP,
Foxp3 transcript abundance ﬁrstly increased in the DLN during the EP
(2.5 +/− 0.7 fold increase on day 4 PI, not shown). Then, as shown in
Fig. 2, Foxp3 transcript abundance increased in the ear pinna (Fig. 2;
6 +/− 2.1 fold increase) from day 19 PI onward, while its abundance
in the DLN decreased. In the same manner as for the CD4 and CD8
transcripts, the levels of Foxp3 transcripts were signiﬁcantly higher in
tissues sampled from mice inoculated with 104 parasites (Fig. 2 and
Table 2).
3.2.3. Proﬁles of cytokine transcript abundances
As T cells play an essential role in the development of inﬂammation at
the inoculation site,wenext focused on the cytokines that operate during
their primary activation and re-activation. The cytokines analysed were
selected based on whether they are beneﬁcial (IL-4, IL-10, TGF-β) or
not (IL-2, IFN-γ, IL-12p40) for parasite development.
In mice inoculated with 104 MP, IL-2 transcript levels were seen to
rise in the ear pinna on day 4 PI (Fig. 3). No other cytokine transcripts
were detected at this time. As the L. major population expanded in the
ear pinna, i.e. during ExP, IL-4 transcript abundance increased signiﬁ-
cantly for instance on 15 PI (Fig. 3; 8-fold increase and Table 3) concom-
itantly with a sharp 100- to 200-fold rise in the L. major population
(compared to day 4 PI) in the ear pinna (Fig. 1A). The highest IL-4
level was detected in both the ear pinna (Fig. 3; a 27-fold increase)
and in ear pinna DLN (3.48 fold increase) at the same time (day 19 PI)
that the L. major population peaked (Fig. 1A). Moreover, a signiﬁcant
positive correlation (r = 0.795, p b 0.001) was observed between the
individual bioluminescence values and individual IL-4 transcript level
values. Concomitantly, IL-10 transcript levels rose markedly in the
DLN (4.8 +/− 2.1 fold increase on day 11 PI, not shown) and in theTable 3
Il-2, Il-4 Il-10 IL-12p40, IFN-γ and TGF-β cytokine transcript abundances in C57BL/6 mice (n =
script abundance in ear pinna and DLN over time, and particularly the temporal window sp
(see Fig. 3). Values correspond to the mean and standard deviation of all the transcript value
are mean fold changes for transcripts (n = 3 independent experiments).
* Signiﬁcant differences (p b 0.05) are indicated for transcript abundances measured in mice i
Transcripts Tissue EP–ExP
104 103
IL-2 Ear 2.3 +/− 0.8 0.9 +
DLN 1.0 +/− 0.4 5.6 +
IL12p40 Ear 1.6 +/− 1.3 1.7 +
DLN 0.5 +/− 0.4 0.9 +
IFN-γ Ear 27.1 +/− 35.9 17.8
DLN 5.1 +/− 4.8 4.8 +
IL-10 Ear 9.3 +/− 6.6 1.8 +
DLN 3.1 +/− 1.6 2.8 +
IL-4 Ear 8.9 +/− 15.3 2.9 +
DLN 2.1 +/− 1.1 0.7 +
TGFβ Ear 1.2 +/− 0.6 0.7 +
DLN 1.9 +/− 0.7 2.2 +ear pinna, with peak values being reached on day 19 PI (18 +/− 2.1
fold increase; Fig. 3). Of note, TGF-β transcript abundance increased
slightly in both the DLN (2.6 +/− 0.9 fold increase on day 15 PI, not
shown) and the ear pinna (Fig. 3; 2.2 +/− 1.0 fold increase on day 19).
Thereafter, both in the ear and DLN, IL-4 transcript abundance de-
creased markedly by day 35 (Fig. 3, Table 3). Concomitantly, a 5-fold
increase in IFN-γ transcripts was measured in the ear pinna between
day 19 and day 35 (Fig. 3). Moreover, over the latter period, not only
did IL-12p40 transcripts rise signiﬁcantly in the L. major-hosting ear
pinna (Fig. 3, Table 3), but also the IFN-γ/IL-4 ratio in the ear pinna in-
creased 29 fold. Concomitantly, a signiﬁcant correlation was noted be-
tween IFN-γ transcript levels and lesion area (r = 0.692, p b 0.001).
These changes correlate with a signiﬁcant reduction in the L. major
population (Fig. 1A) and triggered ear pinna inﬂammatory processes
(Fig. 1C).
In C57BL/6 mice inoculated with 103 MP, IL-2, IL-10 and TGF-β
transcript abundances in the ear pinna were signiﬁcantly different
from those measured in the C57BL/6 mice inoculated with 104 MP
(Fig. 3, Table 3). The lower levels of these cytokine transcripts may ac-
count for the lower amplitude of the transient inﬂammatory processes
shown by the L. major-hosting ear pinna in these animals. Interestingly,
IL-12p40 and IFN-γ transcript abundances reached similar higher values
(Fig. 3, Table 3) than those measured in the tissues sampled from mice
inoculated with 104 parasites.
3.3. Investigation of the immune effectors/regulators that account for con-
comitant immunity in C57BL/6 mice hosting L. major
We previously documented that the immunity that reduces the
L. major population following inoculation with 104 MP in one ear
pinna of C57BL/6 mice [10] also contributes to controlling parasites in24 in each group) inoculated in the ear pinna with 104 or 103 L. major NIH173 MP. Tran-
anning the early and expansion phase (EP–ExP) and the parasite reduction (RP) phase
s obtained in ear pinna or ear pinna-DLN during the corresponding phase. Values shown
noculated with 104 and 103.
RP
104 103
/− 0.4 4.0 +/− 1.6 1.8 +/− 0.5
/− 3.3 3.0 +/− 0.7 6.9 +/− 3.6
/− 1.8 12.2 +/− 3.2 10.6 +/− 4.8
/− 0.6 2.8 +/− 1.3 3.9 +/− 1.6
+/− 30.2 289.5 +/− 88.7 256.6 +/− 194.9
/− 6.0 12.3 +/− 0.3 18.1 +/− 7.0
/− 0.7 15.3 +/− 14.3 5.7 +/− 3.7
/− 1.6 6.8 +/− 6.9 14.7 +/− 16.6
/− 5.5 9.9 +/− 10.1 6.7 +/− 8.1
/− 0.3 0.5 +/− 0.2 0.5 +/− 0.2
/− 0.4 1.4 +/− 0.8 0.8 +/− 0.4
/− 0.7 2.0 +/− 1.6 1.3 +/− 0.8
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is known as concomitant immunity. In the study described herein, we
set about determining the time points at which operated the immune
effectors/regulators that caused concomitant immunity in ear pinna in-
oculated with 104 MP after inoculating with 103 or 104 in the contralat-
eral ear pinna (Fig 4A1, B1). Based on the dose inoculated into the right
ear pinna (primary site), the mice were inoculated in the left ear pinnaFig. 4. Development of concomitant immunity in C57BL/6 mice primo-inoculated with 104 or 1
(n = 10 C57BL/6mice per group). Initial inoculationwith 104 or 103 NIH173MP into the right e
mice given either 104 or 103 L. majorMP into the right ear were then inoculated with 104 L. maj
pinna. Naive C57BL/6mice inoculated on day 22 or 35were used to control the quality of the se
responding controls. The absence of any BLI signal from the left ear pinna (dotted line, open circ
mean that the parasiteswere killed/cleared. A3, B3: Ear thickness (inmm) in groups 1 and 2, and
(right ear) in group 1. Arrows indicate inoculum load and inoculation time ﬁrst in the right ear p
line, open circles), and the shorter duration of this phenotypic trait reﬂect the clinical immunity
line, black circles). Dotted lines (lozenges) show ear pinna thickness values displayed by C57Bwith 104 luciferase-expressing L. major on day 22 or day 35, i.e. when
the L. major population started to fall.
Very precisely, on day 22 PI, the C57BL/6 mice inoculated with 104
MP into the right ear (primary site) were split into two groups. One
was inoculated with 104 MP in the left contralateral (left) ear (second-
ary site), while the other was left without inoculation. A group of naive
mice (Ctrl, i.e. no prior inoculation on day 0) was inoculated with 10403 L. major in the ear dermis. A1, B1: Deﬁnition of experimental and control groups (Ctrl)
ar pinna dermis (primary inoculation site) of C57BL/6mice on day 0 in groups 1 and 2. The
orMP on day 22 (A1) or 35 (B1), respectively, into the dermis of the contralateral (left) ear
cond inoculations. A2, B2: Bioluminescence (in ph/s/ear) in groups 1 and 2, and in the cor-
les) indicates rapid control of the L. major population. Of note, the term “control” does not
in the corresponding controls. Black lines show ear thickness values from the primary site
inna and second in the left. The low and very low values for left ear pinna thickness (dotted
shown by C57BL/6mice given 104 or 103, respectively, in the right ear pinna (continuous
L/6 mice that serve as controls for the second inoculums.
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minescence emission and ear thickness. Consistent with the results of
our previous investigations [10], the inoculation of 104 MP into the
secondary site was followed by the absence of any bioluminescence
(Fig. 4A2) and a very small increase in ear thickness between weeks 3
and 10 PI (Fig. 4A3), indicating that parasite load was controlled at the
challenge site. By contrast, in the Ctrl mice, the proﬁle shown was sim-
ilar to that at the primary site, and this both for i) bioluminescence
(Fig. 4A2) ii) and ear thickness (Fig. 4A3).
On day 35 PI, the C57BL/6 mice primo-inoculated with 103 MP in the
right ear were split in two groups. One was inoculated with 104 MP in
the contralateral left ear pinna (Fig. 4B1, group 2), while the other was
left without inoculation (group 1). A group of naive mice (Ctrl, i.e. no
prior inoculation on day 0) was inoculated with 104 MP and the mice
in the different groups were measured for bioluminescence emission
and ear thickness. As shown in Fig. 4B2 and B3, while the Ctrl ear pinna
showed the expected bioluminescence and ear thickness proﬁles, con-
comitant immunity was operating at the secondary site in the mice
experiencing the L.major population reduction phase at the primary site.
4. Discussion
The approach described herein extends previous analyses in labora-
tory mice inoculated intra-dermally with luciferase-expressing Leish-
mania spp. [8–10,17]. Here, we simultaneously employed quantitative
readout assays in the physiological, low-dose infection model, for once
combined with these very sensitive readout assays, it was possible, in
this experimental model based on inoculation with low doses (103 or
104) of MP into the ear pinna of C57BL/6 mice, to i) follow in real time
the transcript abundance of both amastigote populations and mouse
immune signatures in the tissues and ii) analyse concomitant immuni-
ty. In our study the amastigote population increased and T cell transcriptFig. 5. Real-time determination of i) parasite loadﬂuctuations (bioluminescence), ii) ear thickne
103 L. major. As shown over the three distinct phases, i.e. the early phase— EP, expansion phase
experimental groups (A, B) showed distinct proﬁles for population size of the regulatory (Treg
within the DLN. This Treg/Teff steady state – that was dependent upon inoculum load – acc
with 104 L. major MP. Finally, once established, the steady state between these two T lympho
ear pinna.abundances were measured simultaneously by bioluminescence and
RT-qPCR during the main phases of parasite development in the ear
pinna and ear pinna DLN with which the ear is constantly exchanging
information [18,19]. Despite extensive studies in various models, the
mechanism by which the balance between T regulator/Treg cells and T
effector/Teff cells – which may account in vivo for the induction of an
efﬁcient immune response and concomitant immunity – remains poor-
ly understood [20–22]. Here, we extended these previous data and
focused our analysis on T cell populations and their renewal at the inoc-
ulation site and in ear pinna DLN throughout all the phases of the infec-
tious process.
As outlined in Fig. 5, and depending on theMP inoculum dose in the
ear pinna, the increased CD4, Foxp3, IL10 and TGB-β transcript abun-
dances in both ear pinna and DLN may account for the T lymphocyte
proliferation in the ear pinna DLN. Also, the regular delivery of viable
L. major or L. majormolecules into host cells correlated with themagni-
tude of the primingof both Treg and Teff precursors inDLN. These T cells
may recirculate and accumulate at the infection site where Treg sup-
presses the Teff cell response and consequently promotes parasite
expansion into the ear. Moreover, the reduction in the L. major popula-
tion and the duration of the inﬂammatory processes in the L. major-
hosting ear pinna reﬂects the sustained priming of both effector and
regulatory T lymphocytes and their sustained egress from skin DLN. In-
terestingly, this balance between Treg and Teff cells, which is essential
for the long-term persistence of amastigote-hosting cells in L. major-
resistant C57BL/6 mice [22–24], has been shown to modify the host's
immune response to secondary infection and vaccination. Thus, the
parasite's effect of increasing Treg might contribute to the immune
system's failure to combat the parasitic infection [25,26]. Likewise,
Treg cell depletion can induce a more durable immunity and a better
control of parasite burden than vaccination alone [27]. Our C57BL/6
mouse-based model [9,10] offers an experimental system that can bess, and iii) T lymphocyte subset proﬁles in C57BL/6mouse ear pinna inoculatedwith 104 or
— ExP, and reduction phase— RP, the multi-parametric analysis used to compare the two
) and effector (Teff) T lymphocytes into the ear which were more or less rapidly primed
ounted for the concomitant immunity demonstrated in the contralateral ear inoculated
cyte populations concurs to the persistence of a small number of amastigotes in healed
253E. Giraud et al. / Parasitology International 63 (2014) 245–253used to determine the precise time at which concomitant immunity is
established following inoculation with L. major MP into the ear pinna
of C57BL/6 mice. We demonstrated for both inoculation loads that
i) concomitant immunity, deﬁned as the absence of lesions on re-
inoculation using the same parasite isolate in the contralateral ear,
was not established before effective control of the parasite load at the
primary site and ii) the parasite load at the initial inoculation site was
brought under control at the same time that immunitywas acquired. Al-
together, these ﬁndings demonstrate that i) inoculation with low doses
of parasites (103 and 104) was sufﬁcient to trigger and maintain the ac-
tivation of parasite-targeting effector and tissue-protective regulatory
leukocytes, and ii) the enhanced Treg and Teff cell responses observed
in mice inoculated with the highest dose does not impair concomitant
immunity (Fig. 5). This optimized C57BL/6 mouse-based model should
be very helpful in future analyses of the delicate balance between effec-
tor and regulatory T cells required to optimize the potency and sustain-
ability of leishmaniasis vaccines.
Recourse to sand ﬂies hosting luciferase- or ﬂuorescent probe-
expressing Leishmania MP and to mice genetically engineered for use
with novel ﬂuorescence-based imaging technologies provides us with
valuable opportunities to understand and characterize the discrete
steps in the Leishmania- and laboratory mice-driven processes operat-
ing in the ear pinna and distant tissues. Moreover, both dermotropic
and viscerotropic Leishmania species are delivered by pool blood-
feeding sand ﬂies into mammalian dermis, a tissue compartment locat-
ed beneath the epidermis and its annexes, and known to be populated
by commensal bacteria. It was recently shown that these commensal
bacteria are important for tuning effector T cell responses in the skin.
This contributes to the control of L. major populations in a process
coupled with transient skin damage [28] that precedes the remodelling
of L. major-hosting skin as a niche where a small population persists
which is enriched in morphotypes that are transmissible to any blood-
feeding adult female sand ﬂy.
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